Dana Silber McMahon
VP & Global Chief Compliance Officer at Stryker | Expert in Enterprise Risk Management Strategy | Board Advisor
View LinkedIn ProfileExecutive Overview
Dana Silber McMahon is an expert in enterprise risk management strategy and serves as Vice President and Global Chief Compliance Officer at Stryker. She leads integrated Compliance and Enterprise Risk functions for the $25B global medical technology company operating in 75 countries. Her work focuses on connecting risk assessment, regulatory insight, ethical judgment, and a culture of integrity, inclusion, and high performance to the company's strategic direction, operating plans, and decisions across all business functions. Dana also plays a key role as a board advisor, providing insight on enterprise risk management, regulatory shifts, global operations, and technology-driven issues. She has led significant initiatives to unify compliance and risk activities across regions, embed risk awareness into strategic planning, and strengthen Stryker's ability to operate responsibly and resiliently in complex markets. She is also the President of the Stryker Women's Network. Her career spans more than 20 years in the life sciences industry, including senior legal leadership roles at Novo Nordisk and early practice at O'Melveny & Myers. Dana is known for translating complexity into clarity, integrating risk and strategy, and fostering a culture of integrity, inclusion, accountability, and high performance across global teams. SPECIALTIES Enterprise Risk Management Strategy / Global Compliance Leadership / Board Advisory / Ethics, Integrity & Inclusion / Culture & Organizational Resilience / Strategic Risk Integration / Regulatory Strategy / Cross-Functional Decision Support / AI, Cyber & Privacy Risk Integration
Career Timeline
- StrykerCurrentJun 2017–Present· 9 yrs 3 mos
- Vice President, Global Chief Compliance Officer, Head of Enterprise RiskCurrentJun 2020–Present
- Vice President, Global Chief Compliance Officer, Head of Privacy and Enterprise Risk, Transformed ComplianceJun 2020–Jun 2026
- Chief Legal Counsel — Restructured & Led Global Legal Team to Advise Entire MedTech CompanyJun 2017–Jun 2020
- 2013–May 2017· 4 yrs 4 mos
- Assistant General Counsel | Sr. Corporate Counsel | Corporate Counsel | Senior Attorney | Attorney2013–May 2017
- 2003–May 2017· 14 yrs 4 mos
- Assistant General Counsel — Member of leadership team; supported launch of 1st obesity drug2013–May 2017
- Senior Corporate Counsel — Instrumental in Successful Launch of 2 Blockbuster Drugs2010–2013
- Counsel, Corporate2008–2010
- Senior Attorney — Appointed to leadership team for diabetes franchise2005–2008
- Attorney II — Established Company’s Employment Law Group2003–2005
- Sep 1999–2003· 3 yrs 4 mos
- AssociateSep 1999–2003
Education
Doctor of Law (J.D.)
New York University School of LawBachelor of Arts (B.A.)
English
Hamilton College